Medtronic (NYSE:MDT) reported better-than-expected fiscal Q4 earnings and revenue, while unveiling plans to spin off its ...

Treasury yields have been on the rise in part because of concerns that tax cuts currently under consideration in Washington ...

Medtronic plc (NYSE:MDT) declared a 1.4% hike in its dividend, which took its quarterly dividend to $0.71 per share.

Medtronic plc revealed plans to spin off its underperforming diabetes unit as a separate public company during its fourth quarter 2025 earnings call on May 21. The company expects to complete the ...

Medtronic's Q4 2025 earnings reveal 5.4% growth, Diabetes segment spin-off plans, and strategic focus on high-margin growth drivers.

The new diabetes company will be predominantly business-to-consumer, while Medtronic’s model was more business-to-business.

The separation is also expected to allow Medtronic to retire outstanding shares without impacting cash, leading to further ...

Medtronic bumped up its dividend payout and unveiled plans to spin off its diabetes business as the medical-device company targeted revenue growth for the new fiscal year of roughly 5%.

Medtronic's board has bumped up its quarterly dividend by a penny, to 71 cents, marking the 48th straight year that the medical-technology company has boosted its payout. The new dividend, equal to $2 ...

Medtronic plc (NYSE: MDT) has released its financial results for the fourth quarter and fiscal year 2025, marking a robust conclusion to its fiscal year. The company has also announced a dividend ...

Medtronic (NYSE:MDT) reported fourth-quarter results that surpassed analyst estimates, while its full-year guidance fell ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its fourth quarter ...